{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:41:43Z","timestamp":1793410903630,"version":"4.5.0"},"reference-count":65,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>\n                      The primary compounds of\n                      <jats:italic toggle=\"yes\">Cannabis sativa<\/jats:italic>\n                      , delta-9-tetrahydrocannabinol (\u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC) and cannabidiol (CBD), inflict a direct influence on the endocannabinoid system-a complex lipid signaling network with a central role in neurotransmission and control of inhibitory and excitatory synapses. These phytocannabinoids often interact with endogenously produced endocannabinoids (eCBs), as well as their structurally related\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -acylethanolamines (NAEs), to drive neurobiological, nociceptive, and inflammatory responses. Identifying and quantifying changes in these lipid neuromodulators can be challenging owing to their low abundance in complex matrices.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This article describes a robust liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS) method for the extraction and quantification of the eCBs anandamide and 2-arachidonoylglycerol, along with their congener NAEs oleoylethanolamine and palmitoylethanolamine, and phytocannabinoids CBD, \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC, and 11-Nor-9-carboxy-\u0394\n                      <jats:sup>9<\/jats:sup>\n                      -tetrahydrocannabinol, a major metabolite of \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC. Our method was applied to explore pharmacokinetic and pharmacodynamic effects from intraperitoneal injections of \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC and CBD on circulating levels of eCBs and NAEs in rodent serum.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Detection limits ranged from low nanomolar to picomolar in concentration for eCBs (0.012\u20130.24\u2009pmol\/mL), NAEs (0.059\u2009pmol\/mL), and phytocannabinoids (0.24\u20130.73\u2009pmol\/mL). Our method displayed good linearity for calibration curves of all analytes (\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      &gt;0.99) as well as acceptable accuracy and precision, with quality controls not deviating &gt;15% from their nominal value. Our LC-MS\/MS method reliably identified changes to these endogenous lipid mediators that followed a causal relationship, which was dependent on both the type of phytocannabinoid administered and its pharmaceutical preparation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We present a rapid and reliable method for the simultaneous quantification of phytocannabinoids, eCBs, and NAEs in serum using LC-MS\/MS. The accuracy and sensitivity of our assay infer it can routinely monitor endogenous levels of these lipid neuromodulators in serum and their response to external stimuli, including cannabimimetic agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2021.0181","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T13:48:49Z","timestamp":1652795329000},"page":"657-669","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and\n                    <i>N<\/i>\n                    -Acylethanolamines by Liquid Chromatography\u2013Tandem Mass Spectrometry"],"prefix":"10.1177","volume":"8","author":[{"given":"Timothy A.","family":"Couttas","sequence":"first","affiliation":[{"name":"Brain and Mind Centre, Translational Research Collective, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Boost","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Pahlisch","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliska B.","family":"Sykorova","sequence":"additional","affiliation":[{"name":"Brain and Mind Centre, Translational Research Collective, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia."},{"name":"Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E.","family":"Leweke","sequence":"additional","affiliation":[{"name":"Brain and Mind Centre, Translational Research Collective, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia."},{"name":"Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen University, Goettingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Koethe","sequence":"additional","affiliation":[{"name":"Brain and Mind Centre, Translational Research Collective, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia."},{"name":"Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Endepols","sequence":"additional","affiliation":[{"name":"Department of Multimodal Imaging, Max-Planck-Institute for Neurological Research, Cologne, Germany."},{"name":"Institute of Radiochemistry and Experimental Molecular Imaging, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany."},{"name":"Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany."},{"name":"Forschungszentrum Juelich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Juelich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3559-1846","authenticated-orcid":false,"given":"Cathrin","family":"Rohleder","sequence":"additional","affiliation":[{"name":"Brain and Mind Centre, Translational Research Collective, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia."},{"name":"Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany."},{"name":"Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen University, Goettingen, Germany."},{"name":"Department of Multimodal Imaging, Max-Planck-Institute for Neurological Research, Cologne, Germany."},{"name":"Endosane Pharmaceuticals GmbH, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8163-195X","authenticated-orcid":false,"given":"F. Markus","family":"Leweke","sequence":"additional","affiliation":[{"name":"Brain and Mind Centre, Translational Research Collective, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia."},{"name":"Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1247"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.07.028"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/346561a0"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/365061a0"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199906030-00008"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0539-z"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-013-0470-8"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.03.012"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-142349"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23014"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/35102582"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867321666140303143455"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867023370707"},{"key":"e_1_3_5_15_2","first-page":"588","article-title":"International union of basic and clinical pharmacology","volume":"62","author":"Pertwee RG","year":"2010","unstructured":"Pertwee RG, , Howlett AC, , Abood ME, et al. International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2). Pharmacol Rev. 2010; 62:588\u2013631.","journal-title":"LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2). Pharmacol Rev"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13497"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M305051200"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707460"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2013.02.002"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704199"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.6.3315"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3580249"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2008.00108.x"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja01253a008"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00361"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.04.025"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0741627.x"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12745"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.15"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17030325"},{"key":"e_1_3_5_31_2","first-page":"422","article-title":"Cannabidiol as a potential new type of an antipsychotic","volume":"7","author":"Rohleder C","year":"2016","unstructured":"Rohleder C, , Muller JK, , Lange B, et al. Cannabidiol as a potential new type of an antipsychotic. A critical review of the evidence. Front Pharmacol. 2016; 7:422.","journal-title":"A critical review of the evidence. Front Pharmacol"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.618447"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200312020-00015"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2014.3508"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1166-9"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00315"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.11.018"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00787.x"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2426398"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4439"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.04.010"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2010.04.024"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-010-4103-z"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2006.11.027"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2013.11.004"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1006\/abio.2000.4509"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32651-4"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2016.05.024"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2018.0075"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2947"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2011.08.004"},{"key":"e_1_3_5_52_2","unstructured":"U.S. Department of Health and Human Services Food Drug Administration Center for Drug Evaluation and Research (CDER) et al. Guidance for industry: bioanalytical method validation. 2001."},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/9781118971147.ch5"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007669411738"},{"key":"e_1_3_5_55_2","unstructured":"European Medicines Agency (EMEA). ICH Q2 (R1) Validation of analytical procedures: text and methodology\u2014Step 5. Note for guidance on validation of analytical procedures: text and Methodologiy (CPMP\/ICH\/381\/95). London 1995."},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2011.11.020"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.130"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1159\/000489032"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001507"},{"key":"e_1_3_5_60_2","first-page":"995","article-title":"The rate hypothesis and agonist substitution approaches to cocaine abuse treatment","volume":"42","author":"Gorelick DA","year":"1998","unstructured":"Gorelick DA. The rate hypothesis and agonist substitution approaches to cocaine abuse treatment. Adv Pharmacol (San Diego, Calif). 1998; 42:995\u2013997.","journal-title":"Adv Pharmacol (San Diego, Calif)"},{"key":"e_1_3_5_61_2","first-page":"13","article-title":"Some relationships between addiction and drug delivery to the brain","volume":"120","author":"Oldendorf WH","year":"1992","unstructured":"Oldendorf WH. Some relationships between addiction and drug delivery to the brain. NIDA Res Monogr. 1992; 120:13\u201325.","journal-title":"NIDA Res Monogr"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12785"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.18.13484"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(02)65066-6"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.201467"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-3084(02)00068-3"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2021.0181","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2021.0181","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2021.0181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:11:44Z","timestamp":1777385504000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2021.0181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8,1]]}},"alternative-id":["10.1089\/can.2021.0181"],"URL":"https:\/\/doi.org\/10.1089\/can.2021.0181","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}